Crohn's disease of the mouth.
D000287:Administration, Topical; D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001466:Barium Sulfate; D001706:Biopsy; D003424:Crohn Disease / Q000150:complications / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology; D004848:Epithelium / Q000473:pathology; D006801:Humans; D006854:Hydrocortisone; D008297:Male; D009059:Mouth Diseases / Q000150:complications / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000473:pathology; D009061:Mouth Mucosa / Q000000981:diagnostic imaging / Q000473:pathology; D009067:Mouthwashes / Q000627:therapeutic use; D009761:Nystatin / Q000627:therapeutic use; D009912:Oral Manifestations; D010808:Physical Examination; D011241:Prednisone / Q000627:therapeutic use; D011859:Radiography; D012460:Sulfasalazine / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D014456:Ulcer / Q000209:etiology / Q000473:pathology
D000893:Anti-Inflammatory Agents; D009067:Mouthwashes; D009761:Nystatin; D001466:Barium Sulfate; D012460:Sulfasalazine; D013752:Tetracycline; D011241:Prednisone; D006854:Hydrocortisone